BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2504308)

  • 41. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein.
    Brito CF; Caldas IR; Coura Filho P; Correa-Oliveira R; Oliveira SC
    Scand J Immunol; 2000 Jun; 51(6):595-601. PubMed ID: 10849370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of serum and cell-specific cytokines in humans.
    Jason J; Archibald LK; Nwanyanwu OC; Byrd MG; Kazembe PN; Dobbie H; Jarvis WR
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1097-103. PubMed ID: 11687446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-10 inhibits interleukin-2-induced tumor necrosis factor production but does not reduce toxicity in C3H/HeN mice.
    Lentsch AB; Edwards MJ; Sims DE; Nakagawa K; Wellhausen SR; Miller FN
    J Leukoc Biol; 1996 Jul; 60(1):51-7. PubMed ID: 8699123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
    Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R
    Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.
    Duncombe AS; Meager A; Prentice HG; Grundy JE; Heslop HE; Hoffbrand AV; Brenner MK
    Blood; 1990 Sep; 76(5):1046-53. PubMed ID: 2168224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monocyte-mediated regulation of antigen-driven IFN gamma production by T cells. The role of endogenously produced TNF.
    Mytar B; Wołoszyn M; Ruggiero I; Pryjma J; Zembala M
    Immunol Invest; 1995 Nov; 24(6):897-906. PubMed ID: 8575836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes.
    Danis VA; Franic GM; Rathjen DA; Brooks PM
    Clin Exp Immunol; 1991 Jul; 85(1):143-50. PubMed ID: 1906383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-27 enhances the production of tumour necrosis factor-α and interferon-γ by bone marrow T lymphocytes in aplastic anaemia.
    Li J; Zhao Q; Xing W; Feng J; Wu H; Li H; Ge M; Tian K; Li X; Zhou J; Liu B; Zhang L; Zheng Y; Han ZC
    Br J Haematol; 2011 Jun; 153(6):764-72. PubMed ID: 21506940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.
    Kroesen BJ; Buter J; Sleijfer DT; Janssen RA; van der Graaf WT; The TH; de Leij L; Mulder NH
    Br J Cancer; 1994 Oct; 70(4):652-61. PubMed ID: 7917912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy of advanced acute myeloblastic leukemia with cytarabine and interleukin 2.
    Butturini A; Bonilauri E; Izzi G; Croci G; Franchi F; Santucci MA; Tondelli MT; Castriota Scanderbeg A
    Leuk Res; 1991; 15(8):759-63. PubMed ID: 1910127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns.
    Yamamoto T; Kimura T; Ueta E; Tatemoto Y; Osaki T
    Oncology; 2003; 64(4):407-15. PubMed ID: 12759539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD; Hornicek FJ; Gerstner CG; Kirkwood JM
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
    Ulchaker J; Panuto J; Rayman P; Novick A; Elson P; Tubbs R; Finke JH; Bukowski RM
    J Immunother; 1999 Jan; 22(1):71-9. PubMed ID: 9924702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma.
    Gajewski TF; Fitch FW
    J Immunol; 1990 Jan; 144(2):548-56. PubMed ID: 2104898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells.
    Prehn JL; Landers CJ; Targan SR
    J Immunol; 1999 Oct; 163(8):4277-83. PubMed ID: 10510366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
    Tripp CS; Wolf SF; Unanue ER
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3725-9. PubMed ID: 8097322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of interleukin-2 and CD3 triggering on cytokine gene transcription and secretion in cultured tumor infiltrating lymphocytes.
    Filgueira L; Zuber M; Juretic A; Lüscher U; Caetano V; Harder F; Garotta G; Heberer M; Spagnoli GC
    Cell Immunol; 1993 Aug; 150(1):205-18. PubMed ID: 8343966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 2 immediately after autologous bone marrow transplantation for acute lymphoblastic leukemia--a phase I study.
    Weisdorf DJ; Anderson PM; Blazar BR; Uckun FM; Kersey JH; Ramsay NK
    Transplantation; 1993 Jan; 55(1):61-6. PubMed ID: 8420066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.